The management of hemophilia patients with inhibitors.
Nilsson
I M
IM
Department for Coagulation Disorders, University of Lund, Malmö General Hospital, Sweden.
D005164:Factor IX / Q000276:immunology* / Q000627:therapeutic use*; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002836:Hemophilia B / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D007518:Isoantibodies / Q000097:blood*
D007518:Isoantibodies; D005169:Factor VIII; D005164:Factor IX